Trevi Therapeutics, Inc. (TRVI): Price and Financial Metrics

Trevi Therapeutics, Inc. (TRVI): $3.02

0.00 (0.00%)

POWR Rating

Component Grades

Momentum

C

Stability

C

Sentiment

Quality

C

TRVI Price/Volume Stats

Current price $3.02 52-week high $4.00
Prev. close $3.02 52-week low $0.97
Day low $2.77 Volume 382,500
Day high $3.07 Avg. volume 259,599
50-day MA $3.04 Dividend yield N/A
200-day MA $2.62 Market Cap 212.71M

TRVI Stock Price Chart Interactive Chart >


Trevi Therapeutics, Inc. (TRVI) Company Bio


Trevi Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of treatment for neurologically mediated conditions. It focuses on the formulation of nalbuphine ER, which use to treat chronic pruritus, chronic cough in patients with idiopathic pulmonary fibrosis, and levodopa-induced dyskinesia in patients with Parkinson's disease. The company was founded by Thomas R. Sciascia and Jennifer L. Good on March 17, 2011 and is headquartered in New Haven, CT.


TRVI Latest News Stream


Event/Time News Detail
Loading, please wait...

TRVI Latest Social Stream


Loading social stream, please wait...

View Full TRVI Social Stream

TRVI Price Returns

1-mo N/A
3-mo N/A
6-mo N/A
1-year N/A
3-year N/A
5-year N/A
YTD N/A
2023 N/A
2022 N/A
2021 N/A
2020 N/A
2019 N/A

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!